Background Despite the expanding use of flow-diverting stents (flow diverters—FDs) for middle cerebral artery (MCA) ...
Background Current automatic software uses a fixed apparent diffusion coefficient (ADC) threshold (≤620×10⁻⁶ mm²/s) to ...
Background Endovascular transvenous embolization (TVE) was developed as a curative technique for brain arteriovenous malformations (bAVMs) with small nidi and a single draining vein. We describe a ...
Correspondence to Professor Monika Killer-Oberpfalzer, Research Institute of Neurointervention, Paracelsus Medical University, Salzburg 5020, Austria; m.killer{at}salk.at Purpose To report the results ...
Correspondence to Dr A Arat, Faculty of Medicine, Department of Radiology, Hacettepe University, Ankara, 06100, Turkey; anilarat{at}hotmail.com Objective To report our initial experience with the ...
Background CSF-venous fistulas (CVF) are an important cause of spontaneous intracranial hypotension (SIH). While perineural cysts are thought to be strongly associated with CVF, it remains poorly ...
Correspondence to Dr Adnan H Siddiqui, Neurosurgery and Radiology and Canon Stroke and Vascular Research Center, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY ...
Correspondence to Dr Daniel Sanak, Department of Neurology, Univ Hosp Olomouc, Olomouc 779 00, Czech Republic; daniel.sanak{at}centrum.cz Introduction Despite early management and technical success of ...
Background Early detection of large vessel occlusion (LVO) facilitates triage to an appropriate stroke center to reduce treatment times and improve outcomes. Prehospital stroke scales are not ...
Correspondence to Dr Edgar A Samaniego, Interventional Neuroradiology/Endovascular Neurosurgery Division Department of Neurology, Neurosurgery and Radiology ...
Background Relationships between occlusive clot histopathology, baseline characteristics, imaging findings, revascularization rates, and clinical outcomes of stroke patients with large vessel ...
Background Ticagrelor, a P2Y12 inhibitor, offers a rapid onset and consistent platelet inhibition, making it a viable alternative for dual antiplatelet therapy (DAPT). The optimal ticagrelor dose for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results